Intel Stock Is Up 225% in a Year but Wall Street Still Isn’t Buying It

Intel (NASDAQ: INTC) stock has risen 225.2% over the past year, climbing from less than $18 to a 52-week high of $59.17. If you watched that move from the sidelines, you might be wondering if there’s anything left or did you miss it?

Valuation, forward catalysts, and downside risk each present challenges at the current price.

Valuation: The Stock Has Outrun the Fundamentals

Intel’s financials do not yet support the current price. The company posted a net loss of $591 million in Q4 2025, and full-year FY2025 net income was −$267 million. With negative trailing earnings, the relevant valuation metric is the forward P/E, which sits at 101x. That is an aggressive multiple for a company guiding to $0.00 non-GAAP EPS in Q1 2026.

Wall Street’s $47.23 consensus price target implies 19.9% downside from the current price. The analyst community is deeply skeptical: only nine analysts recommend buying the stock, while 33 rate it as Hold and six rate it as Sell or Strong Sell. Our own price model puts fair value at $51.80 with a Hold rating, implying 12.1% downside from current levels. The stock is still trading near that 52-week high of $59.17.

Forward Catalysts: The Bull Case Is Real, Just Not Yet Proven

The bear case on Intel has been wrong before, and there are legitimate reasons the stock has moved. The data center and artificial intelligence (AI) segment grew 9% year-over-year in Q4, and CFO David Zinsner noted that “DCAI revenue was $4.7 billion, up 15% sequentially, above expectations and the fastest sequential growth this decade. Revenue would have been meaningfully higher if we had more supply.”

Intel 18A, the company’s most advanced process node, is now in high-volume manufacturing in Arizona and Oregon. The Core Ultra Series 3 platform is expected to power more than 200 OEM designs. The custom ASIC business grew more than 50% in 2025 and reached an annualized revenue run rate greater than $1 billion in Q4. Strategic investors have taken notice: Nvidia invested $5.0 billion and SoftBank invested $2.0 billion in Intel common stock.

CEO Lip-Bu Tan has been direct about the timeline: “This will not happen overnight, and our execution needs to continue to improve.” Supply constraints are expected to ease in Q2 2026, which could unlock revenue that demand is already signaling.

Downside Risk: The Entry Point Matters Enormously Here

Intel’s stock dropped 17.03% on the day of the Q4 earnings report, despite a 56.58% EPS beat. That reaction captures the market’s frustration: strong non-GAAP results, but persistent GAAP losses and weak near-term guidance. Intel Foundry posted a $2.51 billion operating loss in Q4 alone, and Q1 2026 revenue guidance of $11.7 billion to $12.7 billion represents a sequential decline from Q4’s $13.67 billion.

Senior executives sold shares in the $44.88 to $49.05 range during the rally, with discretionary sales totaling roughly 238,200 shares across the CLO, CAO, and the foundry operations chief. That selling occurred well below the current price, which adds a note of caution.

The Verdict

The rally has outrun the fundamentals. With the stock near its 52-week high, a forward P/E of 94x, a consensus analyst target nearly 20% below the current price, and Q1 guidance pointing to zero non-GAAP earnings, the risk-reward for a new position at $58.95 is unfavorable. The turnaround story at Intel is real and may ultimately vindicate patient investors, but buying at this price means paying for a recovery that has not yet shown up in the income statement. Investors watching from the sidelines may find the risk-reward more favorable if the stock pulls back toward the $47 to $52 range or after a quarter that demonstrates the foundry segment is closing its losses.